The dopamine D1 receptor antagonist SCH 23390 can exert D1 agonist-like effects on rat nucleus accumbens neurons

Neurosci Lett. 1995 Oct 13;199(1):13-6. doi: 10.1016/0304-3940(95)12025-y.

Abstract

Interactions between the selective dopamine D1-class receptor antagonist SCH 23390 and the dopamine D2-class receptor agonist quinpirole on nucleus accumbens neurons were investigated with extracellular single cell recording and microiontophoresis. Because dopamine D1 receptor stimulation enables many dopamine D2 receptor-mediated effects, SCH 23390 was expected to antagonize quinpirole-induced inhibition of activity. Although concurrent iontophoretic administration of SCH 23390 attenuated the inhibitory effects of quinpirole on most neurons, the antagonist further suppressed the firing of most neurons during attempts to reverse quinpirole-induced inhibition. SCH 23390 also reinstated (enabled) quinpirole-induced inhibition in rats acutely depleted of dopamine. These findings suggest that under certain conditions, SCH 23390 may exert dopamine D1 agonist-like effects.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Benzazepines / pharmacology*
  • Dopamine Agonists / pharmacology*
  • Dopamine Antagonists / pharmacology*
  • Dopamine D2 Receptor Antagonists
  • Ergolines / pharmacology
  • Iontophoresis
  • Male
  • Neurons / drug effects*
  • Nucleus Accumbens / cytology
  • Nucleus Accumbens / drug effects*
  • Patch-Clamp Techniques
  • Quinpirole
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Dopamine D1 / agonists*
  • Receptors, Dopamine D1 / antagonists & inhibitors*
  • Receptors, Dopamine D2 / agonists

Substances

  • Benzazepines
  • Dopamine Agonists
  • Dopamine Antagonists
  • Dopamine D2 Receptor Antagonists
  • Ergolines
  • Receptors, Dopamine D1
  • Receptors, Dopamine D2
  • ecopipam
  • Quinpirole